CURRENT APPROACHES TO EVALUATING THE EFFICIENCY OF TREATMENT FOR REPRODUCTIVE TRACT TUMORS BY RECIST OR GCIG CRITERIA
The present communication discusses unified criteria for assessing the response evaluation criteria in solid tumors (RESIST) that are used to determine complete and partial responses, stabilization, and progression. It gives a classification of gynecological cancer intergroup (GCIG) criteria for elevated CA125 levels in patients with ovarian cancer after termination of primary therapy, which can determine the time of disease progression in patients having isolated growth of the marker during monitoring, without revealing tumor foci.